<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045067">
  <TermName>XK469R</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of leukemia. It belongs to the family of drugs called topoisomerase inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>XK469R</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de la leucemia. Es un tipo de inhibidor de la topoisomerasa.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2006-10-12</DateLastModified>
</GlossaryTerm>
